Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
---|---|---|---|---|---|---|---|---|
2024-02-02 | Spero Therapeutics, Inc. | Keutzer Timothy
(Chief Operating Officer) |
S | Common Stock | D | 30971 | $1.36 - $1.36 | $42,120 |
2024-02-01 | Spero Therapeutics, Inc. | Keutzer Timothy
(Chief Operating Officer) |
A | Common Stock | A | 239731 | $0.00 - $0.00 | $0 |
2024-02-02 | Spero Therapeutics, Inc. | Mahadevia Ankit
(Director) |
S | Common Stock | D | 63795 | $1.37 - $1.37 | $87,399 |
2024-02-02 | Spero Therapeutics, Inc. | JOSEPH TAMARA L
(Chief Legal Officer) |
S | Common Stock | D | 30906 | $1.37 - $1.37 | $42,341 |
2024-02-01 | Spero Therapeutics, Inc. | JOSEPH TAMARA L
(Chief Legal Officer) |
A | Common Stock | A | 239731 | $0.00 - $0.00 | $0 |
2024-02-02 | Spero Therapeutics, Inc. | HAMED KAMAL
(Chief Medical Officer) |
S | Common Stock | D | 28075 | $1.37 - $1.37 | $38,462 |
2024-02-01 | Spero Therapeutics, Inc. | HAMED KAMAL
(Chief Medical Officer) |
A | Common Stock | A | 239731 | $0.00 - $0.00 | $0 |
2024-02-01 | Spero Therapeutics, Inc. | Rajavelu Esther
(See Remarks) |
A | Common Stock | A | 119866 | $0.00 - $0.00 | $0 |
2024-02-02 | Spero Therapeutics, Inc. | Shukla Sath
(CEO and President) |
S | Common Stock | D | 75994 | $1.37 - $1.45 | $107,718 |
2024-02-01 | Spero Therapeutics, Inc. | Shukla Sath
(CEO and President) |
A | Common Stock | A | 679501 | $0.00 - $0.00 | $0 |
2023-11-13 | Spero Therapeutics, Inc. | Rajavelu Esther
(See Remarks) |
A | Common Stock | A | 300000 | $0.00 - $0.00 | $0 |
A | Grant, award or other acquisition |
C | Conversion of Derivative or Security |
D | Disposition to the issuer of issuer equity securities |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability |
G | Bona fide Gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary Transaction |
J | Other acquisition or disposition |
K | Transaction in equity swap or instrument with similar characteristics |
L | Small Acquisition |
M | Exercise or conversion of derivative security |
O | Exercise of out-of-the-money derivative security |
P | Open Market Purchase |
S | Open Market Sale |
U | Disposition pursuant to a tender of shares in a change of control transaction |
V | Transaction Voluntarily Reported |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |